- Home
- MGF vs RPTX Comparison
MGF vs RPTX Comparison
Compare MGF & RPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MGF | RPTX |
|---|---|---|
| Founded | 1987 | 2016 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 102.0M | 92.4M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | MGF | RPTX |
|---|---|---|
| Price | $3.10 | $2.23 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $3.50 |
| AVG Volume (30 Days) | 104.4K | ★ 1.2M |
| Earning Date | 01-01-0001 | 11-14-2025 |
| Dividend Yield | ★ 7.64% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $11,870,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $9.55 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.91 | $0.89 |
| 52 Week High | $3.46 | $4.07 |
Technical Indicators
Market Signals| Indicator | MGF | RPTX |
|---|---|---|
| Relative Strength Index (RSI) | 54.00 | 66.35 |
| Support Level | $3.09 | $2.11 |
| Resistance Level | $3.13 | $2.22 |
| Average True Range (ATR) | 0.02 | 0.09 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 69.23 | 89.23 |
Price Performance
Historical ComparisonAbout MGF MFS Government Markets Income Trust
MFS Government Markets Income Trust is a United States-based diversified, closed-end management investment company. Its investment objective is to seek high current income. The fund invests a majority of the net assets, including borrowings for investment purposes, in U.S. and foreign government securities. The company invest various sectors like U.S. Treasury Securities, Mortgage-Backed Securities, Investment Grade Corporates, Municipal Bonds, Non-U.S. Government Bonds, etc, out of which maximum revenue is gained from U.S. Treasury Securities.
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.